A new research report once again confirms the strength of personalized and measurable stimulation. In other words, exactly the kind of higher-quality treatment that Nexstim has been talking about.
https://www.hcplive.com/view/lower-tms-intensity-correlates-depression-improvement
AI translation aid:
"So, two patients given the same 120% rMT may not receive the same dose to the cerebral cortex at all.
This is therefore very concrete evidence of one of the strengths of Nexstim’s technology:
With Nexstim, it is possible to calculate what the TMS is actually doing to the patient’s cerebral cortex, rather than just how strongly the stimulator delivers the pulse."
If only this would eventually materialize into revenue at some point.
edit. the trade release was already posted above, so I removed the repetition.